Arxx Therapeutics
Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis
Arxx Therapeutics is a company in biotechnology, health care, therapeutics based in Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2018.
The company sits in the biotechnology, health care, therapeutics segment, where it competes on its core product or service.
Its base of operations is Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
Directory data places it at the Private company stage.
Its team size is recorded as c_00011_00050 employees.
| Sector | Biotechnology, Health Care, Therapeutics |
|---|---|
| Headquarters | Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2018 |
| Employees | c_00011_00050 |
| Stage | Private company |
Website: arxxtx.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account